Anne-Britt Majlund Harder, MSc., currently serves as VP, Global Brand Lead for Atopic Dermatitis Global Strategic Marketing at LEO Pharma since May 2021, where responsibilities include co-chairing the Global Asset Team and contributing to the Global Development leadership team. Previously, Anne-Britt held several leadership roles within the healthcare sector, including Director for InMarket Portfolio at Demant and Associate Director at Novo Nordisk, where key achievements include overseeing the Degludec portfolio and managing commercial strategies for various insulin products. In addition to professional roles, Anne-Britt is a member of Women in Life Science Denmark, aimed at enhancing diversity in the industry. Educational credentials encompass a Master's in Management Accounting and Communication from Copenhagen Business School, along with various advanced courses in Design Thinking, Medical Product Innovation, and Lean Six Sigma.
Sign up to view 1 direct report
Get started
This person is not in any teams